The Dylan Gemelli Podcast
The Dylan Gemelli Podcast

Oct 17, 2026 · 1h 7m

C60’s longevity promise meets supplement-market skepticism

Episode #173: Scientist Reveals the Nobel Prize Discovery That Could Slow Aging! - Featuring Chris Burres

The conversation examines whether a molecule linked to striking animal results can move responsibly from industrial material to human supplement.

3 key takeaways
  1. 1Chris Burris traces ESS60 from carbon-nanomaterial research and industrial applications to a longevity-focused supplement.
  2. 2The rat longevity study drove human interest, but the episode distinguishes animal findings, testimonials, biomarkers, and formal clinical evidence.
  3. 3Manufacturing, oil-based formulation, authenticity testing, and FDA and FTC requirements shape whether consumers can trust the product.

Don't miss

Chris and Dylan taste the olive-oil ESS60 formulation while discussing its peppery flavor, dosing, and premium cost.

The brief

Chris Burris explains how fullerene C60 moved from carbon-nanomaterial research into ESS60, a formulation marketed for longevity, energy, sleep, and recovery.

The molecule’s industrial uses include inks, batteries, tires, and solar cells, while its structure and Nobel Prize connection frame the scientific backstory.

A toxicity study in rats unexpectedly found substantially longer survival, helping spark interest in human use even though animal results do not establish human benefit.

The episode’s central tension is credibility: Chris describes FDA and FTC requirements, manufacturing controls, HPLC monitoring, and tests finding little or no claimed molecule in competitors.

Chris and Dylan taste the olive-oil formulation on camera, turning an abstract debate about bioavailability and premium pricing into a concrete product test.

The takeaway is cautious: testimonials and biomarker signals may justify further study, but they remain distinct from controlled clinical evidence of longevity.

Books & mentions

Some links are affiliate links — PodLume may earn a commission if you buy.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.

C60’s longevity promise meets supplement-market skepticism · PodLume